Fred Alger Management, LLC Iovance Biotherapeutics, Inc. Transaction History

Fred Alger Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$7.59 - $17.47 $1.39 Million - $3.19 Million	182,765 New	182,765 $2.71 Million
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $539,626 - $989,848	-18,822 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$28.04 - $50.26 $350,079 - $627,496	-12,485 Reduced 39.88%	18,822 $873,000
Q3 2020 Nov 13, 2020	SELL	$27.75 - $36.3 $1.01 Million - $1.32 Million	-36,295 Reduced 53.69%	31,307 $1.03 Million
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $1.21 Million - $1.83 Million	44,602 Added 193.92%	67,602 $1.86 Million
Q1 2020 May 15, 2020	SELL	$19.54 - $38.85 $429,880 - $854,700	-22,000 Reduced 48.89%	23,000 $689,000
Q4 2019 Feb 14, 2020	SELL	$17.95 - $29.41 $771,850 - $1.26 Million	-43,000 Reduced 48.86%	45,000 $1.25 Million
Q3 2019 Nov 14, 2019	SELL	$17.99 - $26.0 $305,830 - $442,000	-17,000 Reduced 16.19%	88,000 $1.6 Million
Q2 2019 Aug 14, 2019	BUY	$9.78 - $24.52 $97,800 - $245,200	10,000 Added 10.53%	105,000 $2.58 Million
Q1 2019 May 14, 2019	BUY	$8.41 - $11.26 $798,950 - $1.07 Million	95,000 New	95,000 $903,000
Q3 2018 Nov 14, 2018	SELL	$11.25 - $17.7 $90,000 - $141,600	-8,000 Closed	0 $0
Q2 2018 Jul 19, 2018	BUY	$12.45 - $16.95 $99,600 - $135,600	8,000 New	8,000 $102,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.46B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.